Ginkgo rises on expansion of gene testing program

Ginkgo Bioworks Holdings

06/11/2023 13:29

** Shares of biotech Ginkgo Bioworks  DNA.N  rise 2.4% to
$1.68 premarket
    ** Co says it is expanding its work with the U.S Centers for
Disease Control and Prevention's Traveler-based Genomic
Surveillance program (TGS) to test for more than 30 additional
pathogens along with SARS-CoV-2
    ** TGS uses sample collection methods like voluntary nasal
swabbing from arriving international travelers at U.S. airports,
to detect new SARS-CoV-2 variants and other pathogens
    ** Up to last close, shares down 3% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))